Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Segulah Medical Acceleration Denmark ApS
APS
Dissolved
CVR 42032085
Hørmarken 2
Virksomhedsrådgivning og anden rådgivning om driftsledelse · NACE 702200
Est. 2021
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2023
DKK 3,4M
+2% vs 2022
EBITDA margin
7.8%
+29% vs 2022
Equity ratio
54.3%
Financial strength
Net profit 2023
DKK 201K
+31% vs 2022
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
Key figures
Annual report 2023
Revenue
DKK 3,4M
+2%
EBITDA
DKK 264K
+29%
Net profit
DKK 201K
+31%
Total assets
DKK 1M
+67%
Equity
DKK 556K
+57%
Employees
1
—
Company information
Legal name
Segulah Medical Acceleration Denmark ApS
CVR number
42032085
Legal form
Anpartsselskab
NACE code
702200 · Virksomhedsrådgivning og anden rådgivning om driftsledelse
Founded
13. januar 2021
Share capital
DKK 40.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2023-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af 1 direktør eller af den samlede direktion.
Contact
Address
Hørmarken 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Virksomhedsrådgivning og anden rådgivning om driftsledelse
Companies in Furesø
All Denmark companies
Revenue
DKK millions
0M
1M
2M
3M
5M
4M
2021
3M
2022
3M
2023
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
Income statement
DKK thousands
Item
2021
2022
2023
Revenue
3.532
3.322
3.390
Staff expenses
-3.282
-3.117
-3.126
EBITDA
250
204
264
Depreciation & amort.
-0
-0
-0
EBIT
250
204
264
Net financials
-47
-7
-2
Profit before tax
202
198
262
Tax
41
44
61
Net profit
161
154
201
Balance sheet
DKK thousands
Item
2021
2022
2023
Total assets
718
613
1.024
Equity
201
355
556
Long-term debt
0
0
0
Short-term debt
517
258
468
Total debt
517
258
468
Financial ratios
5-year trend
EBITDA margin
7.8%
This company
15.8%
Market median
-51% vs market
2021
2023
Equity ratio
54.3%
This company
38.2%
Market median
+42% vs market
2021
2023
Return on equity
36.2%
This company
18.4%
Market median
+97% vs market
2021
2023
Net profit margin
5.9%
This company
8.1%
Market median
-27% vs market
2021
2023
Asset turnover
3.31×
This company
1.12×
Market median
+196% vs market
2021
2023
Debt / equity
0.84×
This company
0.62×
Market median
+35% vs market
2021
2023
Annual reports & filings
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-13 – 2021-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Former (3)
AS
Alexander Schou Schrøder
Management
Management
2021 – 2023
QB
Qasir Bashir
Chief Executive Officer
Chief Executive Officer
2023 – 2024
JR
James Roger Gunnarsson
Management
Management
2021 – 2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Segulah Medical Acceleration AB
Individual
100%
100%
2021
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Segulah Medical Acceleration Denmark ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Alexander Schou Schrøder
Management
0 companies
Qasir Bashir
Chief Executive Officer
0 companies
James Roger Gunnarsson
Management
0 companies